| Radiation plus procarbazine, CCNU, and vincristine in low-grade glioma JC Buckner, EG Shaw, SL Pugh, A Chakravarti, MR Gilbert, GR Barger, ... New England Journal of Medicine 374 (14), 1344-1355, 2016 | 1079 | 2016 |
| The central role of perilipin a in lipid metabolism and adipocyte lipolysis J Tansey, C Sztalryd, E Hlavin, A Kimmel, C Londos IUBMB life 56 (7), 379-385, 2004 | 341 | 2004 |
| Targeting SREBP-1-driven lipid metabolism to treat cancer D Guo, E Hlavin Bell, P Mischel, A Chakravarti Current pharmaceutical design 20 (15), 2619-2626, 2014 | 314 | 2014 |
| Lipid metabolism emerges as a promising target for malignant glioma therapy D Guo, EH Bell, A Chakravarti CNS oncology 2 (3), 289-299, 2013 | 188 | 2013 |
| Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma F Yan, L Alinari, ME Lustberg, L Katherine Martin, HM Cordero-Nieves, ... Cancer research 74 (6), 1752-1765, 2014 | 185 | 2014 |
| Association of MGMT promoter methylation status with survival outcomes in patients with high-risk glioma treated with radiotherapy and temozolomide: an analysis from the NRG … EH Bell, P Zhang, BJ Fisher, DR Macdonald, JP McElroy, GJ Lesser, ... JAMA oncology 4 (10), 1405-1409, 2018 | 174 | 2018 |
| Comprehensive genomic analysis in NRG oncology/RTOG 9802: a phase III trial of radiation versus radiation plus procarbazine, lomustine (CCNU), and vincristine in high-risk low … EH Bell, P Zhang, EG Shaw, JC Buckner, GR Barger, DE Bullard, ... Journal of Clinical Oncology 38 (29), 3407-3417, 2020 | 171 | 2020 |
| SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non–Small Cell Lung Cancer EH Bell, AR Chakraborty, X Mo, Z Liu, K Shilo, S Kirste, P Stegmaier, ... Clinical Cancer Research 22 (10), 2396-2404, 2016 | 133 | 2016 |
| Molecular-based recursive partitioning analysis model for glioblastoma in the temozolomide era: a correlative analysis based on NRG oncology RTOG 0525 EH Bell, SL Pugh, JP McElroy, MR Gilbert, M Mehta, AC Klimowicz, ... JAMA oncology 3 (6), 784-792, 2017 | 97 | 2017 |
| Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813 S Chang, P Zhang, JG Cairncross, MR Gilbert, JP Bahary, CA Dolinskas, ... Neuro-oncology 19 (2), 252-258, 2017 | 88 | 2017 |
| Initiation of DNA interstrand cross‐link repair in mammalian cells EM Hlavin, MB Smeaton, PS Miller Environmental and molecular mutagenesis 51 (6), 604-624, 2010 | 67 | 2010 |
| Distortion-dependent unhooking of interstrand cross-links in mammalian cell extracts MB Smeaton, EM Hlavin, T Mcgregor Mason, AM Noronha, CJ Wilds, ... Biochemistry 47 (37), 9920-9930, 2008 | 67 | 2008 |
| miR-15b/16-2 regulates factors that promote p53 phosphorylation and augments the DNA damage response following radiation in the lung M Rahman, F Lovat, G Romano, F Calore, M Acunzo, EH Bell, ... Journal of Biological Chemistry 289 (38), 26406-26416, 2014 | 63 | 2014 |
| Single-isocenter multitarget stereotactic radiosurgery is safe and effective in the treatment of multiple brain metastases JD Palmer, NT Sebastian, J Chu, D DiCostanzo, EH Bell, J Grecula, ... Advances in Radiation Oncology 5 (1), 70-76, 2020 | 61 | 2020 |
| Adverse prognosis of glioblastoma contacting the subventricular zone: Biological correlates S Berendsen, E Van Bodegraven, T Seute, WGM Spliet, M Geurts, ... PloS one 14 (10), e0222717, 2019 | 53 | 2019 |
| miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma T Cui, EH Bell, J McElroy, AP Becker, PM Gulati, M Geurts, N Mladkova, ... Oncogene 38 (16), 2923-2936, 2019 | 53 | 2019 |
| Distinct cellular pools of perilipin 5 point to roles in lipid trafficking SR Bartholomew, EH Bell, T Summerfield, LC Newman, EL Miller, ... Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids …, 2012 | 53 | 2012 |
| Genomic characterization of non–small-cell lung cancer in African Americans by targeted massively parallel sequencing LH Araujo, C Timmers, EH Bell, K Shilo, PE Lammers, W Zhao, ... Journal of Clinical Oncology 33 (17), 1966-1973, 2015 | 49 | 2015 |
| Cross-link structure affects replication-independent DNA interstrand cross-link repair in mammalian cells EM Hlavin, MB Smeaton, AM Noronha, CJ Wilds, PS Miller Biochemistry 49 (18), 3977-3988, 2010 | 46 | 2010 |
| DDB2 represses ovarian cancer cell dedifferentiation by suppressing ALDH1A1 T Cui, AK Srivastava, C Han, D Wu, N Wani, L Liu, Z Gao, M Qu, N Zou, ... Cell Death & Disease 9 (5), 561, 2018 | 40 | 2018 |
Minesh MehtaMiami Cancer InstituteEmail verificata su fiu.edu
